Pediatric News - Lamictal
Wednesday, January 7th, 2009 (lamotrigine, GlaxoSmithKline)
The FDA expanded the indications for Lamictal (lamotrigine) tablets to include add-on therapy for partial seizures in children aged 2 years and older. Lamotrigine is already indicated as adjunctive therapy for children aged 2 years and older for the generalized seizures of Lennox-Gastaut syndrome.
* Recommended Dosage: Available as 2-mg, 5-mg, or 25-mg oral tablets that may be swallowed whole, chewed, or dispersed in water or diluted fruit ju…
